Published in J Exp Med on May 01, 1994
Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med (2006) 2.18
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest (1997) 1.69
Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med (1995) 1.68
Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol (2012) 1.54
Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J Exp Med (1998) 1.48
Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc Natl Acad Sci U S A (1999) 1.46
Bladder Cancer Immunotherapy: BCG and Beyond. Adv Urol (2012) 1.27
Interleukin 10 induced augmentation of delayed-type hypersensitivity (DTH) enhances Mycobacterium bovis bacillus Calmette-Guérin (BCG) mediated antitumour activity. Clin Exp Immunol (2003) 1.12
Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J Exp Med (2000) 1.07
Role of Th1 and Th2 cells in anterior chamber-associated immune deviation. Immunology (1996) 0.93
Role of Th17 cells in skin inflammation of allergic contact dermatitis. Clin Dev Immunol (2013) 0.88
Critical role of IL-10 in the induction of low zone tolerance to contact allergens. J Clin Invest (2003) 0.86
Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunity. J Immunol Res (2014) 0.81
Nickel, palladium and rhodium induced IFN-gamma and IL-10 production as assessed by in vitro ELISpot-analysis in contact dermatitis patients. BMC Immunol (2008) 0.80
Requirement for splenic CD4+ T cells in the immune privilege of the anterior chamber of the eye. Clin Exp Immunol (1999) 0.80
Th2 cytokines, IgE and mast cells play a crucial role in the induction of para-phenylenediamine-induced contact hypersensitivity in mice. Clin Exp Immunol (2003) 0.80
Keratinocyte gene therapy for systemic diseases. Circulating interleukin 10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin. J Clin Invest (1998) 0.79
Cell death and the immune response: a lesson from the privileged. J Clin Immunol (1997) 0.76
Preventive and therapeutic potential of placental extract in contact hypersensitivity. Int Immunopharmacol (2010) 0.75
Tumor necrosis factor-α, monocyte chemoattractant protein-1 and intercellular adhesion molecule-1 increase during the development of a 2,4-dinitrofluorobenzene-induced immediate-type dermatitis in rats. Inflamm Res (2013) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med (1991) 16.81
Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med (1989) 15.15
IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol (1991) 11.04
Contact and delayed hypersensitivity in the mouse. I. Active sensitization and passive transfer. Immunology (1968) 5.03
IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol (1993) 4.65
Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J Exp Med (1990) 4.30
Biological properties of interleukin 10. Immunol Today (1992) 3.62
Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol (1990) 3.54
Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J Exp Med (1991) 3.34
Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci U S A (1991) 3.09
IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J Immunol (1992) 2.78
Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci U S A (1992) 2.77
IL-10: a novel cytotoxic T cell differentiation factor. J Immunol (1991) 2.32
Studies on the sensitization of animals with simple chemical compounds. XII. The influence of excision of allergenic depots on onset of delayed hypersensitivity and tolerance. J Exp Med (1969) 2.28
Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J Exp Med (1991) 2.24
Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J Immunol (1993) 2.20
Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J Exp Med (1992) 2.15
Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol (1990) 2.10
Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. J Immunol (1992) 2.04
Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol (1993) 2.00
Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J Exp Med (1993) 1.94
Murine B7 antigen provides an efficient costimulatory signal for activation of murine T lymphocytes via the T-cell receptor/CD3 complex. Proc Natl Acad Sci U S A (1992) 1.92
Identification and induction of keratinocyte-derived IL-10. J Immunol (1992) 1.87
Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J Clin Invest (1990) 1.85
Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific Th1 clones. J Immunol (1988) 1.83
Studies on the sensitization of animals with simple chemical compounds. XI. The fate of labeled picryl chloride and dinitrochlorobenzene after sensitizing injections. J Exp Med (1969) 1.62
Two integrin-binding peptides abrogate T cell-mediated immune responses in vivo. Proc Natl Acad Sci U S A (1991) 1.50
Phenotypic characteristics of antigen-bearing cells in the draining lymph nodes of contact sensitized mice. Immunology (1990) 1.46
MHC class II expression by Langerhans' cells and lymph node dendritic cells: possible evidence for maturation of Langerhans' cells following contact sensitization. Immunology (1991) 1.42
Reduced contact sensitivity reactions in mice treated with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1. J Immunol (1993) 1.38
Ultraviolet B light-induced alterations in epidermal Langerhans cells are mediated in part by tumor necrosis factor-alpha. Photodermatol Photoimmunol Photomed (1990) 1.18
Modified immunological status of anti-IL-10 treated mice. Cell Immunol (1993) 1.17
Antigen-independent processes in antigen-specific immunity. A role for alpha 4 integrin. J Immunol (1993) 1.07
Role of IL-10 on antigen-presenting cell function for schistosomal egg-specific monoclonal T helper cell responses in vitro and in vivo. J Immunol (1993) 0.95
Langerhans cells that migrate to skin after intravenous infusion regulate the induction of contact hypersensitivity. J Immunol (1990) 0.91
L3T4 (CD4+) cells that mediate contact sensitivity to trinitrochlorobenzene express I-A determinants. Cell Immunol (1991) 0.87
Neonatal induction of transplantation tolerance in mice is associated with in vivo expression of IL-4 and -10 mRNAs. Transplant Proc (1993) 0.86
Selective impairment of T lymphocyte activation following contact sensitization with oxazolone. Int Arch Allergy Appl Immunol (1991) 0.86
Regulatory responses in contact sensitivity: afferent suppressor T cells inhibit the activation of efferent suppressor T cells. Cell Immunol (1991) 0.82
Contact-sensitizing and tolerogenic properties of 2,4-dinitrothiocyanobenzene. Int Arch Allergy Appl Immunol (1986) 0.80
Phenotypic determination of T-lymphocytes responding to chemotactic stimulation from fMLP, IL-8, human IL-10, and epidermal lymphocyte chemotactic factor. Arch Dermatol Res (1992) 0.78
Ia antigen expressed by keratinocytes can be the molecule of antigen presentation in contact sensitivity. J Invest Dermatol (1987) 0.77
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med (1999) 9.78
Arrangement of RNA and proteins in the spliceosomal U1 small nuclear ribonucleoprotein particle. Nature (2001) 2.93
Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Exp Med (1999) 1.88
Structure of keyhole limpet hemocyanin type 1 (KLH1) at 15 A resolution by electron cryomicroscopy and angular reconstitution. J Mol Biol (1997) 1.75
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J Clin Invest (1997) 1.69
Structural organisation of the head-to-tail interface of a bacterial virus. J Mol Biol (2001) 1.63
The 70S Escherichia coli ribosome at 23 A resolution: fitting the ribosomal RNA. Structure (1995) 1.54
Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J Exp Med (1998) 1.48
Three-dimensional structure of the anaphase-promoting complex. Mol Cell (2001) 1.31
Mutation of Pro-258 in transmembrane domain 6 constitutively activates the G protein-coupled alpha-factor receptor. Proc Natl Acad Sci U S A (1996) 1.28
Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells. Immunity (1998) 1.26
A vision of cell death: insights into immune privilege. Immunol Rev (1997) 1.18
Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis. J Immunol (1999) 1.14
Structure of the 13-fold symmetric portal protein of bacteriophage SPP1. Nat Struct Biol (1999) 1.14
Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. J Immunol (1995) 1.08
Structure of Lumbricus terrestris hemoglobin at 30 A resolution determined using angular reconstitution. J Struct Biol (1995) 0.99
The immune response and the eye: a role for TNF alpha in anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci (1994) 0.95
DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells. Cancer Gene Ther (2007) 0.94
Regulation of Fas ligand-induced apoptosis by TNF. J Immunol (2001) 0.92
Induction of necrotic tumor cell death by TRAIL/Apo-2L. Apoptosis (2003) 0.91
Expression of a maize storage protein gene in petunia plants is not restricted to seeds. Plant Physiol (1988) 0.91
Enhancement of Ad5-TRAIL cytotoxicity against renal cell carcinoma with histone deacetylase inhibitors. Cancer Gene Ther (2006) 0.91
Connective tissue growth factor expression in the rat remnant kidney model and association with tubular epithelial cells undergoing transdifferentiation. Vet Pathol (2000) 0.89
Intrinsic versus imposed curvature in cyclical oligomers: the portal protein of bacteriophage SPP1. EMBO J (1996) 0.85
Structure of a molluscan hemocyanin didecamer (HtH1 from Haliotis tuberculata) at 12 A resolution by cryoelectron microscopy. J Mol Biol (2000) 0.84
Afr1p regulates the Saccharomyces cerevisiae alpha-factor receptor by a mechanism that is distinct from receptor phosphorylation and endocytosis. Genetics (1998) 0.81
Regulation of CD95 ligand expression: a key element in immune regulation? Behring Inst Mitt (1996) 0.79
Nonsyndromic tooth agenesis patterns and associated developmental dental anomalies: a literature review with radiographic illustrations. Minerva Stomatol (2013) 0.77
Treatment of liver metastases with moderate peritoneal carcinomatosis by hepatectomy and cytoreductive surgery followed by immediate post-operative intraperitoneal chemotherapy: feasibility and preliminary results. Hepatogastroenterology (1999) 0.76
Radiation therapy in the treatment of early glottic carcinoma: the experience of Villejuif. Radiother Oncol (1989) 0.76
Cell death and the immune response: a lesson from the privileged. J Clin Immunol (1997) 0.76
Control of massive cardiac haemorrhage by balloon catheter. Thorax (1973) 0.75
In vivo distribution & action of emetine on protein synthesis in hamster tissues. Indian J Exp Biol (1983) 0.75
Direct determination of cadmium in urine using graphite furnace atomic absorption spectrometry with Zeeman-effect background correction. Analyst (1989) 0.75
Isolation cart wins award in achievement contest. Hosp Top (1967) 0.75
Simplified method for the determination of plasma 18-hydroxycorticosterone. J Chromatogr (1988) 0.75
[Pancreatic lymphoma with papillary localization revealed by digestive hemorrhage]. Gastroenterol Clin Biol (1994) 0.75
Action of certain anaesthetic agents on erythrocyte calcium permeability. Indian J Exp Biol (1981) 0.75
Esophageal reconstruction: an experimental approach to the control of reflux after esophageal resection. Can J Surg (1975) 0.75
Transient exotropia after posterior spinal fusion in a child: a new case. J AAPOS (2000) 0.75
Determination of chromium in human urine by graphite furnace atomic absorption spectrometry with Zeeman-effect background correction. Analyst (1988) 0.75
Helping the homeless. Interview by Kelly A Rzepecki. Mich Nurse (1991) 0.75
High-performance liquid chromatography in the radioimmunoassay of urinary tetrahydroaldosterone. J Chromatogr (1987) 0.75
[Radiotherapy of cancer limited to the vocal cords]. Ann Otolaryngol Chir Cervicofac (1989) 0.75